liberals FOOLED by Elon’s shocking surprise

Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…

Click here to discover the real reason Elon Musk became buddy-buddy with Trump.

Linda Baddour Biography and Net Worth

Director of Waters

Ms. Baddour is currently serving on the board of directors of Advarra, Signant Health and Waters Corporation (“Waters”). Waters is the world’s leading specialty measurement company focused on improving human health and well-being through the application of advanced analytical science technologies. With approximately 7,000 employees worldwide, Waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Ms. Baddour has over twenty years of experience in the Life Sciences industry. From June 2007 to October 2018, Ms. Baddour served as Executive Vice President and CFO of PRA Health Sciences (“PRA”). PRA is a global contract research organization and data science company serving the pharmaceutical and biotech industry for more than 40 years. PRA, formerly a Genstar portfolio company, grew from approximately 3000 employees to over 17,000 during her tenure with the company.

In addition to her eleven years at PRA, Ms. Baddour worked at Pharmaceutical Product Development, Inc (“PPD”) from November 1995 to May 2007. She served as CFO at PPD from 2002 until her departure to join PRA. At PPD, she also managed the company’s M&A and information technology strategies. Prior to being named CFO at PPD, she was Treasurer and Chief Accounting Officer.

Ms. Baddour is also a certified public accountant.

What is Linda Baddour's net worth?: The estimated net worth of Linda Baddour is at least $839,587.50 as of March 13th, 2024. Ms. Baddour owns 2,250 shares of Waters stock worth more than $839,588 as of December 26th. This net worth evaluation does not reflect any other assets that Ms. Baddour may own. Learn More about Linda Baddour's net worth.
How do I contact Linda Baddour?: The corporate mailing address for Ms. Baddour and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on Linda Baddour's contact information.
Has Linda Baddour been buying or selling shares of Waters?: Linda Baddour has not been actively trading shares of Waters during the last quarter. Most recently, Linda Baddour sold 500 shares of the business's stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $355.54, for a transaction totalling $177,770.00. Following the completion of the sale, the director now directly owns 2,250 shares of the company's stock, valued at $799,965. Learn More on Linda Baddour's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Richard Fearon (Director), Michael Harrington (SVP), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, Waters insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $332,900.00. During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,500 shares worth more than $1,624,330.00. The most recent insider tranaction occured on May, 28th when Director Richard H Fearon bought 1,000 shares worth more than $332,900.00. Insiders at Waters own 0.8% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 5/28/2024.

Linda Baddour Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2024	Sell	500	$355.54	$177,770.00	2,250
8/16/2021	Sell	1,260	$408.99	$515,327.40
5/13/2021	Sell	1,249	$314.99	$393,422.51	3,046

Linda Baddour Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $373.15

$367.16

$373.55

50 Day Range

MA: $368.15

$322.57

$392.01

2 Week Range

Now: $373.15

$279.24

$397.02

Volume

105,584 shs

Average Volume

445,089 shs

Market Capitalization

$22.16 billion

P/E Ratio

35.61

Dividend Yield

N/A

Beta

1.01